GlassScriptPhysician profile
Milena Bonilla
NPI 1477702892
$15,475.34
in general payments reported to CMS, 2019-2025
30 companies · $3,305 in 2025
The $3,305 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,602 · 2022: $3,179 · 2023: $3,469 · 2024: $2,920 · 2025: $3,305.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,154 · Education: $290 · Consulting Fee: $250.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,154.39 |
| Education | $289.97 |
| Consulting Fee | $250.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,172.17 | 2021-2025 | |
| Janssen Biotech, INC. | $1,883.42 | 2021-2025 | Tremfya, Simponi Aria, Simponi |
| Genzyme Corporation | $1,363.88 | 2021-2025 | |
| Incyte Corporation | $1,046.28 | 2021-2025 | Opzelura, Opzelura |
| Leo Pharma INC. | $1,006.02 | 2021-2025 | Adbry, Anzupgo |
| Novartis Pharmaceuticals Corporation | $912.70 | 2021-2025 | |
| Pfizer INC. | $864.29 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $742.86 | 2021-2025 | Winlevi, Absorica Ld |
| Ucb, INC. | $727.95 | 2021-2025 | Bimzelx, Cimzia |
| Regeneron Healthcare Solutions, INC. | $666.23 | 2021-2025 | Dupixent |
| E.R. Squibb & Sons, L.L.C. | $655.12 | 2022-2024 | Sotyktu |
| Lilly USA, LLC | $634.55 | 2021-2025 | Taltz, Olumiant, Ebglyss |
| Dermavant Sciences, INC. | $594.80 | 2022-2024 | Vtama |
| Galderma Laboratories, L.P. | $380.22 | 2021-2024 | Oracea, Aklief, Epsolay |
| Helsinn Therapeutics (U.S.), INC. | $371.73 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $295.82 | 2021-2025 | Otezla, Otezla |
| Janssen Scientific Affairs, LLC | $264.58 | 2022 | |
| Medimetriks Pharmaceuticals, INC. | $250.00 | 2024 | Clindacin Etz, Neo-Synalar |
| Arcutis Biotherapeutics, INC. | $127.32 | 2023-2025 | Zoryve |
| Organon LLC | $112.06 | 2025 | Vtama |
| Almirall LLC | $105.68 | 2023-2024 | Klisyri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.46 | 2022-2024 | Spevigo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $65.93 | 2021-2025 | Siliq, Cabtreo, Jublia |
| Biofrontera INC. | $40.04 | 2022-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Dermira, INC. | $24.65 | 2021 | |
| Boston Scientific Corporation | $24.26 | 2025 | General - Pain Management |
| Kyowa Kirin, INC. | $22.93 | 2022 | |
| Epi Health, LLC | $21.50 | 2022 | |
| Botanix Sb INC | $18.87 | 2025 | Sofdra |
| Journey Medical Corporation | $13.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milena Bonilla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.